β-blockers may be detrimental in frail patients with heart failure with preserved ejection fraction

ConclusionsUse of β-blockers was significantly associated with worse prognosis specifically in patients with HFpEF and high CFS, but not in those with low CFS. Use of β-blockers in HFpEF patients with frailty may need careful attention.Graphical abstract
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research